Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVAC-1 in healthy adults
NCT05155982Phase 1Withdrawn
- Sponsor
- University of Saskatchewan
- Start
- Jun 2022
- Primary completion
- Jun 2023
- Modality
- Peptides, Vaccines & Immunotherapeutics
01
Overview
Phase 1, randomised, double-blind trial of CoVac-1 in coronavirus disease 2019 (COVID-19), sponsored by University of Saskatchewan. Planned start Jun 2022; status: withdrawn.
02
Drugs
CoVac-1
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05155982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05155982.